Citation: Ml. Gordon, THE ROLE OF CLOBETASOL PROPIONATE EMOLLIENT 0.05-PERCENT IN THE TREATMENT OF PATIENTS WITH DRY, SCALY, CORTICOSTEROID-RESPONSIVE DERMATOSES, Clinical therapeutics, 20(1), 1998, pp. 26-39
Citation: Ml. Gordon et Tp. Walsh, OUTSOURCING TECHNOLOGY IN GOVERNMENT - OWNED, CONTROLLED, OR REGULATED INSTITUTIONS, Journal of government information, 24(4), 1997, pp. 267-283
Authors:
LEDBETTER JA
FRANCISCO JA
SIEGALL CB
GILLILAND LK
HOLLENBAUGH D
ARUFFO A
SIADAK AW
MISCHELPETTY N
GROSMAIRE LS
GORDON ML
BROWN TJ
MORANDAVIS P
MITTLER RS
KIENER PA
NADLER SG
Citation: Ja. Ledbetter et al., AGONISTIC ACTIVITY OF A CD40-SPECIFIC SINGLE-CHAIN FV CONSTRUCTED FROM THE VARIABLE REGIONS OF MAB G28-5, Critical reviews in immunology, 17(5-6), 1997, pp. 427-435
Authors:
SADEH JS
RUDIKOFF D
GORDON ML
BOWDEN J
GOLDMAN BD
LEBWOHL M
Citation: Js. Sadeh et al., PUSTULAR AND ERYTHRODERMIC PSORIASIS COMPLICATED BY ACUTE RESPIRATORY-DISTRESS SYNDROME, Archives of dermatology, 133(6), 1997, pp. 747-750
Citation: Ml. Gordon et Nl. Cohen, EFFICACY OF AUDITORY BRAIN-STEM RESPONSE AS A SCREENING-TEST FOR SMALL ACOUSTIC NEUROMAS, The American journal of otology, 16(2), 1995, pp. 136-139
Authors:
SUTHERLAND CJ
ESSER KA
ELSOM VL
GORDON ML
HARDEMAN EC
Citation: Cj. Sutherland et al., IDENTIFICATION OF A PROGRAM OF CONTRACTILE PROTEIN GENE-EXPRESSION INITIATED UPON SKELETAL-MUSCLE DIFFERENTIATION, Developmental dynamics, 196(1), 1993, pp. 25-36